Immune-related mechanisms and immunotherapy in extragonadal germ cell tumors

被引:5
作者
Xiu, Weigang [1 ]
Pang, Jiyun [1 ,2 ]
Hu, Yang [3 ]
Shi, Huashan [4 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Div Thorac Tumor Multimodal Treatment 1, Chengdu, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Peoples R China
关键词
extragonadal germ cell tumor; immunohistochemistry; immunotherapy; mechanism; diagnosis; YOLK-SAC; EMBRYONAL CARCINOMA; PHASE-II; C-KIT; MARKERS; SERUM; CANCER; SALL4; CHORIOCARCINOMA; INFLAMMATION;
D O I
10.3389/fimmu.2023.1145788
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of reviewExtragonadal germ cell tumors (EGCTs) are relatively rare tumors, accounting for 1%-5% of all GCTs. In this review, we summarize the current research progress regarding the pathogenesis, diagnosis, and treatment of EGCTs from an immunology perspective. Recent findingsThe histological origin of EGCTs is related to a gonadal origin, but they are located outside the gonad. They show great variation in morphology and can occur in the cranium, mediastinum, sacrococcygeal bone, and other areas. The pathogenesis of EGCTs is poorly understood, and their differential diagnosis is extensive and challenging. EGCT behavior varies greatly according to patient age, histological subtype, and clinical stage. This review provides ideas for the future application of immunology in the fight against such diseases, which is a hot topic currently.
引用
收藏
页数:10
相关论文
共 100 条
[1]   Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206 [J].
Adra, N. ;
Einhorn, L. H. ;
Althouse, S. K. ;
Ammakkanavar, N. R. ;
Musapatika, D. ;
Albany, C. ;
Vaughn, D. ;
Hanna, N. H. .
ANNALS OF ONCOLOGY, 2018, 29 (01) :209-214
[2]   Phase II trial of pembrolizumab in patients (pts) with incurable platinum refractory germ cell tumors (GCT). [J].
Adra, Nabil ;
Althouse, Sandra K. ;
Ammakkanavar, Natraj Reddy ;
Radovich, Milan ;
Albany, Costantine ;
Vaughn, David J. ;
Einhorn, Lawrence H. ;
Hanna, Nasser H. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3]   TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia [J].
Akizuki, Keiichi ;
Sekine, Masaaki ;
Kogure, Yasunori ;
Kameda, Takuro ;
Shide, Kotaro ;
Koya, Junji ;
Kamiunten, Ayako ;
Kubuki, Yoko ;
Tahira, Yuki ;
Hidaka, Tomonori ;
Kiwaki, Takumi ;
Tanaka, Hiroyuki ;
Sato, Yuichiro ;
Kataoka, Hiroaki ;
Kataoka, Keisuke ;
Shimoda, Kazuya .
BMC CANCER, 2020, 20 (01)
[4]   Clinicopathologic Analysis of Choriocarcinoma as a Pure or Predominant Component of Germ Cell Tumor of the Testis [J].
Alvarado-Cabrero, Isabel ;
Hernandez-Toriz, Narciso ;
Paner, Gladell P. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (01) :111-118
[5]  
[Anonymous], 1959, CELL HUMORAL ASP HYP
[6]   Cancer in kidney transplant recipients [J].
Au, Eric ;
Wong, Germaine ;
Chapman, Jeremy R. .
NATURE REVIEWS NEPHROLOGY, 2018, 14 (08) :508-520
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   Serum tumor markers in the evaluation of male germ cell tumors [J].
Barlow, LaMont J. ;
Badalato, Gina M. ;
McKiernan, James M. .
NATURE REVIEWS UROLOGY, 2010, 7 (11) :610-617
[9]   On the Origin of Testicular Germ Cell Tumors: From Gonocytes to Testicular Cancer [J].
Baroni, Tiziano ;
Arato, Iva ;
Mancuso, Francesca ;
Calafiore, Riccardo ;
Luca, Giovanni .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[10]   Diagnostic value of markers M2A, OCT3/4, AP-2γ, PLAP and c-KIT in the detection of extragonadal seminomas [J].
Biermann, K. ;
Klingmueller, D. ;
Koch, A. ;
Pietsch, T. ;
Schorle, H. ;
Buettner, R. ;
Zhou, H. .
HISTOPATHOLOGY, 2006, 49 (03) :290-297